Pharmacogenomics of Antiplatelet Response - II (PARes-II)

Completed · Phase 4

Conditions studied: Atherothrombosis

In brief

This clinical trial is examining the effect of 4-week aspirin therapy on platelet transcriptome in persons at high-risk for myocardial infarction or stroke due to family history of early-onset coronary artery disease.

Key facts

Study ID
NCT01894555
Run by
Johns Hopkins University
People needed
33
Starts
2013-01-01
Expected to finish
2014-08-01
Last updated by the study team
2017-01-09

Who can join

Age: 45 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.